Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production

UK medical cannabis group woos patients to buy into the business


A British medicinal cannabis company based on the Isle of Man is selling up to 25 per cent of its equity to patients in the UK, giving them influence in the production and availability of a drug they struggle to obtain reliably and affordably.
Grow Lab Organics last year became the first company to gain a licence to grow and export cannabis from the Isle of Man, which has its own government but is in a customs union within the UK.
This story originally appeared on: Financial Times - Author:William Wallis